Key result
UCP3 deficiency in mice drives larger infarct sizes after ischemia-reperfusion injury via enhanced superoxide generation.
Why the study?
The role of mitochondrial uncoupling protein 3 (UCP3) in reducing oxidative stress and facilitating fatty acid oxidation after myocardial ischemia-reperfusion injury was unclear.
Does UCP3 deficiency increase myocardial vulnerability to ischemia-reperfusion injury in mice?
Does UCP3 deficiency increase myocardial vulnerability to ischemia-reperfusion injury in mice?
UCP3 deficiency increases myocardial vulnerability to ischemia-reperfusion injury by promoting enhanced superoxide generation and mitochondrial structural changes.
Should not yet change clinical management of ischemia-reperfusion injury; extends preclinical evidence for UCP3 in mitochondrial cardioprotection.
Myocardial ischemia-reperfusion (IR) injury may result in cardiomyocyte dysfunction. Mitochondria play a critical role in cardiomyocyte recovery after IR injury. The mitochondrial uncoupling protein 3 (UCP3) has been proposed to reduce mitochondrial reactive oxygen species (ROS) production and to facilitate fatty acid oxidation. As both mechanisms might be protective following IR injury, we investigated functional, mitochondrial structural, and metabolic cardiac remodeling in wild-type mice and in mice lacking UCP3 (UCP3–KO) after IR. Results showed that infarct size in isolated perfused hearts subjected to IR ex vivo was larger in adult and old UCP3–KO mice than in equivalent wild-type mice, and was accompanied by higher levels of creatine kinase in the effluent and by more pronounced mitochondrial structural changes. The greater myocardial damage in UCP3–KO hearts was confirmed in vivo after coronary artery occlusion followed by reperfusion. S1QEL, a suppressor of superoxide generation from site IQ in complex I, limited infarct size in UCP3–KO hearts, pointing to exacerbated superoxide production as a possible cause of the damage. Metabolomics analysis of isolated perfused hearts confirmed the reported accumulation of succinate, xanthine and hypoxanthine during ischemia, and a shift to anaerobic glucose utilization, which all recovered upon reoxygenation. The metabolic response to ischemia and IR was similar in UCP3–KO and wild-type hearts, being lipid and energy metabolism the most affected pathways. Fatty acid oxidation and complex I (but not complex II) activity were equally impaired after IR. Overall, our results indicate that UCP3 deficiency promotes enhanced superoxide generation and mitochondrial structural changes that increase the vulnerability of the myocardium to IR injury.
No takes yet. Share an insight, caveat, or question.
Sánchez-Pérez et al. (2023) studied Myocardial ischemia-reperfusion injury. UCP3 deficiency (UCP3-KO) vs. Wild-type mice was evaluated on Infarct size and mitochondrial structural changes after ischemia-reperfusion. UCP3 deficiency in mice promotes enhanced superoxide generation and mitochondrial structural changes, leading to larger infarct sizes and increased vulnerability to myocardial ischemia-reperfusion injury.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: